Press Release September 30, 2024 Lyon, France, sep 30, 2024 – Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million DOWNLOAD Poxel press release Share Previous Post TheraVet announces a strategic transformation project aimed at creating a leader in human idiopathic pulmonary fibrosis Next Post Establishment of a renewable equity financing line of a maximum amount of €2 million to support the ramp-up of the Revin industrial site